H.C. Wainwright Highlights Its Top Picks Ahead Of NACFC 2014 By: Benzinga via Benzinga October 01, 2014 at 10:15 AM EDT In a report published Wednesday, H.C. Wainwright analyst Andrew S. Fein reiterated a Neutral rating and $85.00 price target on Vertex ... Read More >> Related Stocks: Vertex Pharmaceuticals